Computational Molecular Biology 2024, Vol.14, No.3, 115-124 http://bioscipublisher.com/index.php/cmb 121 personalized medicine promises to deliver tailored therapeutic solutions, although challenges such as data privacy, ethical considerations, and accessibility need to be addressed. Figure 2 Representation of the basic workflow of computational drug design approaches. The CADD approaches include structureand ligand-based drug design approaches, pharmacophore modeling, virtual screening, molecular docking, ADMET, dynamics simulation, and MM-GBSA or MM-PBSA approaches (Adopted from Hasan et al., 2022)
RkJQdWJsaXNoZXIy MjQ4ODYzNA==